title: Authors' Reply: association of HIV-infection and antiretroviral therapy with levels of endothelial progenitor cells and subclinical atherosclerosis.
authors.forename: Dulcenombre
authors.initials: D
authors.lastname: Gómez-Garre
authors.forename: Vicente
authors.initials: V
authors.lastname: Estrada
authors.forename: Adriana
authors.initials: A
authors.lastname: Ortega-Hernández
authors.forename: Paloma
authors.initials: P
authors.lastname: Muñoz-Pacheco
authors.forename: Sergio
authors.initials: S
authors.lastname: Serrano-Villar
authors.forename: Mario
authors.initials: M
authors.lastname: Avila
authors.forename: Manuel
authors.initials: M
authors.lastname: Fuentes-Ferrer
authors.forename: Teresa
authors.initials: T
authors.lastname: Tejerina
authors.forename: Arturo
authors.initials: A
authors.lastname: Fernández-Cruz
mesh_terms: D053687:Adult Stem Cells / Q000473:pathology*; D019380:Anti-HIV Agents / Q000009:adverse effects*; D050197:Atherosclerosis / Q000209:etiology* / Q000473:pathology*; D042783:Endothelial Cells / Q000473:pathology*; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D008297:Male
chemical_list: D019380:Anti-HIV Agents